NAN
NANOSONICS LIMITED ORDINARYNanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related consumables and accessories. The company also provides infection control and decontamination products and related technologies. In addition, it is involved in the research, development, and commercialization of the CORIS system, an automated technology designed to transform flexible endoscope reprocessing. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
NAN
NAN
NANOSONICS LIMITED ORDINARY
Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related consumables and accessories.
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 28 Aug | — | — |
| 27 Aug | — | — |
| 26 Aug | — | — |
| 25 Aug | 6.78% | — |
| 24 Aug | 6.37% | — |
| 21 Aug | 6.42% | — |
| 20 Aug | 6.63% | — |
| 19 Aug | 6.82% | — |
| 18 Aug | 6.83% | — |
| 17 Aug | 6.87% | — |
| 14 Aug | 6.89% | — |
| 13 Aug | 6.82% | — |
Nanosonics Limited (NAN) Short Interest Summary
Nanosonics Limited (NAN) currently has 6.78% of its shares sold short (20.3 million shares, worth approximately $55.3 million), based on ASIC short position data reported on 25 August 2026 (T+4 reporting lag). That makes NAN the #44 most shorted stock on the ASX most shorted list. Short interest in NAN is down 0.06% over the past week and up 0.13% over the past month. NAN is part of the Health Care sector on the ASX.
Recent NAN Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 25 Aug 2026 | 6.78% | 20.3M | $3.05 |
| 24 Aug 2026 | 6.37% | 19.0M | $3.68 |
| 21 Aug 2026 | 6.42% | 19.2M | $3.63 |
| 20 Aug 2026 | 6.63% | 19.8M | $3.60 |
| 19 Aug 2026 | 6.82% | 20.4M | $3.64 |
| 18 Aug 2026 | 6.83% | 20.4M | $3.63 |
| 17 Aug 2026 | 6.87% | 20.5M | $3.54 |
| 14 Aug 2026 | 6.89% | 20.6M | $3.55 |
| 13 Aug 2026 | 6.82% | 20.4M | $3.55 |
| 12 Aug 2026 | 6.86% | 20.5M | $3.54 |
NAN Short Selling — Frequently Asked Questions
What is Nanosonics Limited (NAN)'s current short interest?
Nanosonics Limited (NAN) currently has a short interest of 6.78% of total shares outstanding. This means 6.78% of NAN's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is NAN heavily shorted on the ASX?
NAN has a moderate level of short interest at 6.78%. While below the heavily shorted threshold of 10%, this indicates notable bearish positioning. NAN is currently ranked #44 among the most shorted stocks on the ASX.
What does short interest mean for NAN investors?
Short interest in NAN shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 6.78%, NAN's short interest is at a moderate level. See our short squeeze candidates and days to cover analysis for more context.
Where does this NAN short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for NAN.